COVID-19 Isolation and Treatment for Children After 5 Days
Your child can end isolation after 5 days if they are fever-free for 24 hours without fever-reducing medications, symptoms are improving, and ideally a rapid antigen test is negative. If symptoms persist or the antigen test remains positive, continue isolation through day 10.
Isolation Recommendations
The current evidence supports a 5-day minimum isolation period with specific criteria for ending isolation early 1:
Day 5-9 exit criteria:
- No fever for ≥24 hours without fever-reducing medications
- Symptoms resolving or absent
- Negative rapid antigen test (if available)
Important caveat: Research shows that 54.3% of children still test positive on antigen tests between days 5-9, with positivity declining over time 1. Children with symptomatic infection are significantly more likely to remain antigen-positive (9.63 times higher odds) 1.
If unable to meet exit criteria: Continue isolation through day 10 from symptom onset (or positive test if asymptomatic).
After ending isolation: Your child should wear a well-fitting mask around others through day 10, as they may still be infectious 1.
Treatment Approach
For Mild to Moderate COVID-19 (Most Children)
Treatment is primarily supportive 2, 3:
- Fever management: Acetaminophen or ibuprofen as needed
- Hydration: Encourage regular fluid intake (avoid excessive amounts)
- Rest: Allow adequate sleep and activity as tolerated
- Monitoring: Watch for worsening symptoms, particularly increased breathing difficulty
Symptom-Specific Management
For bothersome cough:
- Avoid lying flat on back (makes coughing less effective) 4
- Honey for children >1 year old 4
- Short-term codeine or morphine oral solution only if cough is severely distressing 4
Red flags requiring immediate medical attention:
- Difficulty breathing or shortness of breath
- Persistent chest pain or pressure
- New confusion or inability to wake
- Bluish lips or face
- Severe or persistent vomiting
- Dehydration signs
Antiviral Treatment (Select Cases Only)
Remdesivir may be considered for 2:
- Adolescents ≥12 years, ≥40 kg with severe COVID-19 requiring supplemental oxygen (but not mechanical ventilation)
- Adolescents ≥12 years, ≥40 kg at high risk for severe disease who are within 7 days of symptom onset and do NOT require oxygen
Nirmatrelvir/ritonavir (Paxlovid) may be considered for 2:
- Adolescents ≥12 years, ≥40 kg at high risk for severe disease
- Within 5 days of symptom onset
- Do NOT require supplemental oxygen
High-risk conditions include: obesity, diabetes, immunocompromising conditions, chronic lung disease, sickle cell disease, congenital heart disease, neurodevelopmental disorders 5.
What NOT to Do
- Do NOT use corticosteroids for mild to moderate COVID-19 in children 2
- Corticosteroids are reserved only for severe/critical cases requiring oxygen support
- Most children do NOT need antiviral medications 3
Key Clinical Pearls
Antigen testing strategy: If you have access to rapid antigen tests, testing on day 5 can help guide isolation decisions. A negative test supports ending isolation (with other criteria met), while a positive test indicates continued viral shedding and need for ongoing isolation 1.
Vaccination status matters: Children who received primary COVID-19 vaccination series are 40% less likely to test positive on antigen tests during days 5-9, supporting potentially shorter infectious periods 1.
Most children do well: The vast majority of pediatric COVID-19 cases are mild 6, 3. Serious complications like multisystem inflammatory syndrome in children (MIS-C) are rare but require immediate medical attention if fever persists beyond 3 days with multiorgan symptoms 7.
Watch for MIS-C warning signs (rare, typically 2-6 weeks after infection): persistent fever ≥3 days, severe abdominal pain, rash, conjunctivitis, hypotension, or cardiac symptoms 7.